{
    "questions": [
        {
            "id": "643d41e757b1c7a315000037",
            "type": "list",
            "exact_answer": [
                [
                    "latuda"
                ],
                [
                    "schizophrenia"
                ]
            ]
        },
        {
            "id": "64179139690f196b5100002f",
            "type": "list",
            "exact_answer": [
                [
                    "mlpa"
                ],
                [
                    "ml"
                ],
                [
                    "mlpa, and subsequently, if negative, samples were sequenced to detect point mutations"
                ],
                [
                    "pa"
                ],
                [
                    "mlpa, and subsequently, if negative, samples were sequenced"
                ]
            ]
        },
        {
            "id": "644289c457b1c7a31500005e",
            "type": "list",
            "exact_answer": [
                [
                    "hearing loss"
                ],
                [
                    "foot dorsiflexor, hip girdle weakness, and hearing loss"
                ],
                [
                    "hearing"
                ],
                [
                    "periscapular, foot dorsiflexor, hip girdle weakness, and hearing loss"
                ],
                [
                    "hip girdle weakness, and hearing loss"
                ]
            ]
        },
        {
            "id": "641791ca690f196b51000031",
            "type": "list",
            "exact_answer": [
                [
                    "dystrophinopathies"
                ],
                [
                    "dystrophinopathies, limb-girdle muscular dystrophies, emery-dreifuss muscular dystrophy"
                ],
                [
                    "limb-girdle muscular dystrophies, emery-dreifuss muscular dystrophy"
                ],
                [
                    "dystrophinopathies, limb-girdle muscular dystrophies"
                ],
                [
                    "emery-dreifuss muscular dystrophy"
                ]
            ]
        },
        {
            "id": "644291fa57b1c7a31500005f",
            "type": "list",
            "exact_answer": [
                [
                    "1"
                ],
                [
                    "dm type 1"
                ],
                [
                    "type 1"
                ],
                [
                    "type 2 (dm2) is considered less severe than dm type 1"
                ],
                [
                    "dm type 2 (dm2) is considered less severe than dm type 1"
                ]
            ]
        },
        {
            "id": "63f741a633942b094c000009",
            "type": "list",
            "exact_answer": [
                [
                    "nivolumab"
                ]
            ]
        },
        {
            "id": "64163568690f196b5100001b",
            "type": "list",
            "exact_answer": [
                [
                    "exons 3-9"
                ],
                [
                    "exons 3"
                ],
                [
                    "exons"
                ],
                [
                    "exons 3-9 encompassing a mutational hot spot"
                ],
                [
                    "exons 3-"
                ]
            ]
        },
        {
            "id": "6442869857b1c7a31500005d",
            "type": "list",
            "exact_answer": [
                [
                    "southern blot"
                ],
                [
                    "southern blot based dna test"
                ],
                [
                    "southern"
                ],
                [
                    "southern blot based dna"
                ],
                [
                    "simple pcr probe synthesis and labelling procedure, thus facilitating and accelerating the standard southern blot"
                ]
            ]
        },
        {
            "id": "641794e7690f196b51000036",
            "type": "list",
            "exact_answer": [
                [
                    "autism"
                ],
                [
                    "epilepsy, autism"
                ],
                [
                    "autism, and attention deficit disorder"
                ],
                [
                    "low iq scores, epilepsy, autism"
                ],
                [
                    "autism, and attention deficit"
                ]
            ]
        },
        {
            "id": "63ee5c78f36125a426000001",
            "type": "list",
            "exact_answer": [
                [
                    "interleukin-4"
                ],
                [
                    "interleukin"
                ],
                []
            ]
        },
        {
            "id": "64316f8e57b1c7a315000016",
            "type": "list",
            "exact_answer": [
                [
                    "mesenchymal"
                ],
                [
                    "cells"
                ]
            ]
        },
        {
            "id": "641c5201690f196b51000040",
            "type": "list",
            "exact_answer": [
                [
                    "inflammatory polyneuropathies"
                ],
                [
                    "inflammatory polyneuropathies."
                ],
                [
                    "inflammatory polyneuropath"
                ],
                [
                    "polyneuropathies"
                ],
                [
                    "ies"
                ]
            ]
        },
        {
            "id": "643c183b57b1c7a31500002c",
            "type": "list",
            "exact_answer": []
        },
        {
            "id": "64402f6f57b1c7a315000045",
            "type": "list",
            "exact_answer": [
                [
                    "1.8 or 9.0 g/day"
                ],
                [
                    "1"
                ],
                [
                    "1.8 or 9.0"
                ],
                [
                    "1.8 or 9.0 g/day), or a matching dose of nondeuterated ethyl linoleate"
                ],
                [
                    "1.8 or 9.0 g"
                ]
            ]
        },
        {
            "id": "6440f85c57b1c7a315000051",
            "type": "list",
            "exact_answer": [
                [
                    "premature"
                ],
                [
                    "pipp"
                ],
                [
                    "neonatal"
                ],
                [
                    "nips"
                ]
            ]
        },
        {
            "id": "6402ba49201352f04a000004",
            "type": "list",
            "exact_answer": [
                [
                    "atezolizumab"
                ],
                [
                    "atezolizumab (840 mg, days 1 and 15 of each 28-day cycle) plus oral cobimetinib"
                ],
                [
                    "ate"
                ],
                [
                    "atezoliz"
                ],
                [
                    "atezo"
                ]
            ]
        },
        {
            "id": "641791b9690f196b51000030",
            "type": "list",
            "exact_answer": [
                [
                    "dystroglycanopathies"
                ],
                [
                    "merosin-deficient"
                ]
            ]
        },
        {
            "id": "643d3e6157b1c7a315000034",
            "type": "list",
            "exact_answer": [
                [
                    "b-type natriuretic peptide"
                ],
                [
                    "b-type natriuretic peptide /bnp"
                ],
                [
                    "natriuretic peptide"
                ],
                [
                    "peptide"
                ],
                [
                    "b"
                ]
            ]
        }
    ]
}